TP53 and central nervous system cancer: Previously, it has been reported that p53 wild-type cell lines may be responsive to SVIP depletion by siRNA, thereby leading to decreased p53 expression and increased cell proliferation of glioma cells; however, p53 mutant cell lines may not [17].